Based in Sweden, Fidabio is a startup founded in 2020. Brouky records 1 investor associated with the company.
Fidabio develops the FIDA (Flow-Induced Dispersion Analysis) technology for in-solution biophysical analysis, enabling fast, label-free, multi-parametric protein characterization and binding studies in native-like sample conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.